bpc 157 fda compounding category panel backs compounded BPC-157, KPV peptides in win for RFK Jr An FDA advisory committee voted
An FDA advisory committee voted Thursday to remove compounding restrictions on four peptides despite little evidence the products are safe or effective for medical use. In a series of 8 6 votes (with Peptide Therapy in Austin, TX Austin Plastic Surgeon Dr. Chuma FDA has removed certain bulk drug substances that were placed on the category two list and has announced it will consult the Pharmacy Compounding Advisory Committee (PCAC) for potential future inclusion of FDA Advisory Committee Recommends Adding BPC 157 to Compounding List American Med Spa Association
Pay in 4 interest-free payments of $7.41 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12


